Sonodynamic Therapy Complements PD-L1 Immune Checkpoint Inhibition in a Murine Model of Pancreatic Cancer

被引：0
|
作者：
Nesbitt, Heather [1 ]
Logan, Keiran [1 ]
Thomas, Keith [1 ]
Callan, Bridgeen [1 ]
Gao, Jinhui [1 ]
Mc Kaig, Thomas [1 ]
Taylor, Mark [2 ]
Love, Mark [3 ]
Stride, Eleanor [4 ]
Mc Hale, Anthony [1 ]
Callan, John [1 ]
机构：
[1] Ulster Univ, Coleraine, Londonderry, North Ireland
[2] Mater Hosp, Belfast, Antrim, North Ireland
[3] Royal Victoria Hosp, Belfast, Antrim, North Ireland
[4] Univ Oxford, Oxford, England
来源：
BRITISH JOURNAL OF SURGERY | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O-P04
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Exosomal immune checkpoint protein (PD-L1): Hidden player in PD-1/PD-L1 blockade immunotherapy resistance in oral cancer
    Rajanathadurai, Jeevitha
    Sindya, Jospin
    Madar, Inamul Hasan
    Perumal, Elumalai
    ORAL ONCOLOGY, 2024, 151
  • [42] Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out
    Schmitt, Andreas Michael
    Larkin, James
    Patel, Sapna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (02)
  • [43] Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions
    Kim, Eun-Hye
    Kawamoto, Masuki
    Dharmatti, Roopa
    Kobatake, Eiry
    Ito, Yoshihiro
    Miyatake, Hideyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [44] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Sabrina Heynckes
    Karam Daka
    Pamela Franco
    Annette Gaebelein
    Jan Hendrik Frenking
    Roberto Doria-Medina
    Irina Mader
    Daniel Delev
    Oliver Schnell
    Dieter Henrik Heiland
    BMC Cancer, 19
  • [45] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Heynckes, Sabrina
    Daka, Karam
    Franco, Pamela
    Gaebelein, Annette
    Frenking, Jan Hendrik
    Doria-Medina, Roberto
    Mader, Irina
    Delev, Daniel
    Schnell, Oliver
    Heiland, Dieter Henrik
    BMC CANCER, 2019, 19 (1)
  • [46] PD-L1 Expression in Pancreatic Cancer
    Zheng, Lei
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (06):
  • [47] The effect of PLAG on the PD-L1 immune-checkpoint drug therapy in the MB49 bladder cancer syngeneic model
    Kim, Guen Tae
    Yoon, Sun Young
    Park, Ji Sun
    Sohn, Ki-Young
    Kim, Jae Wha
    CANCER RESEARCH, 2020, 80 (16)
  • [48] PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?
    Al-Ahmadie, H.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1658 - 1659
  • [49] EFFECTIVENESS OF PD-L1 INHIBITION AS A THERAPEUTIC OPTION OF CANCER IMMUNOTHERAPY IN PANCREATIC CANCER
    Kameta, Eri
    Shibata, Wataru
    Sato, Takeshi
    Sue, Soichiro
    Maeda, Shin
    GASTROENTEROLOGY, 2017, 152 (05) : S189 - S189
  • [50] Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
    Hoshi, Ryunosuke
    Gorospe, Kristyna A.
    Labouta, Hagar I.
    Azad, Taha
    Lee, Warren L.
    Thu, Kelsie L.
    PHARMACEUTICS, 2024, 16 (09)
12345